Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Outpatient Respiratory Syncytial Virus Infections and Novel Preventive Interventions
2024
· University Medical Center Utrecht,
· Respiratory Syncytial Virus NETwork (ReSViNET) Foundation
This article focuses on respiratory syncytial virus (RSV) infections that occur outside of hospitals. It describes new ways to prevent these infections, which are common …
Ask aRCie
Rapid Review Showed That Real-World Results on How Nirsevimab Prevented Respiratory Syncytial Virus Hospitalisations Were Similar to Randomised Trials
This brief report describes a study on nirsevimab, a treatment to prevent RSV hospitalizations in infants. Real-world results from studies in Luxembourg, Spain, and the …
Effectiveness of Nirsevimab Immunoprophylaxis Against Respiratory Syncytial Virus-Related Outcomes in Hospital and Primary Care Settings: A Retrospective Cohort Study in Infants in Catalonia (Spain)
This study in Catalonia, Spain looks at the effectiveness of nirsevimab, a monoclonal antibody for RSV, in infants under 6 months old. The study shows …
Nirsevimab to Reduce Infant Morbidity From Respiratory Syncytial Virus
This article describes how nirsevimab, a long-acting monoclonal antibody, helps prevent respiratory syncytial virus (RSV) infections in infants. RSV is a common virus that can …
Nirsevimab Clinical Guidance and VFC Ordering [Letter]
This letter provides clinical guidance on the use of nirsevimab (Beyfortus), a monoclonal antibody that protects infants and toddlers from respiratory syncytial virus (RSV). Information …
Nirsevimab Updates
This webinar provides updates on nirservimab. Providers will learn about the RSV season in Hawaii, the recommended immunizations for RSV prevention, and best practices for …
Obtaining Beyfortus Through the Vaccines for Children Program
This webpage explains how birthing hospitals can acquire Beyfortus through the Vaccines for Children (VFC) program. Hospitals can get Beyfortus through direct purchase or the …
Nirsevimab-A Breakthrough in Respiratory Syncytial Virus Bronchiolitis
2024
· Paris Cité University,
· McGill University
This article comments on immunization programs with nirsevimab that began in 2023 in some countries like France, with its impact being studied in recent publications. …
Provider Guidance for the Prevention of Respiratory Syncytial Virus in Infants: Maternal Vaccination Versus Infant Monoclonal Antibody Treatment
This article provides guidance on preventing respiratory syncytial virus (RSV) in infants. It describes two new FDA-approved options: Beyfortus, a monoclonal antibody for infants, and …
Respiratory Syncytial Virus (RSV) Vaccines and Therapeutics
This webpage provides guidance and resources on respiratory syncytial virus (RSV) and immunization. RSV is a common lung virus that mainly affects young children under …